Logo image of IRO.CA

INTER-ROCK MINERALS INC (IRO.CA) Stock Fundamental Analysis

TSX-V:IRO - TSX Venture Exchange - CA4583541079 - Common Stock - Currency: CAD

0.71  +0.02 (+2.9%)

Fundamental Rating

5

IRO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 17 industry peers in the Food Products industry. While IRO has a great health rating, its profitability is only average at the moment. IRO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IRO was profitable.
IRO had a positive operating cash flow in the past year.
In the past 5 years IRO has always been profitable.
Each year in the past 5 years IRO had a positive operating cash flow.
IRO.CA Yearly Net Income VS EBIT VS OCF VS FCFIRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

IRO's Return On Assets of 5.95% is amongst the best of the industry. IRO outperforms 94.12% of its industry peers.
IRO has a better Return On Equity (13.84%) than 82.35% of its industry peers.
The Return On Invested Capital of IRO (12.85%) is better than 94.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IRO is significantly below the industry average of 91.65%.
Industry RankSector Rank
ROA 5.95%
ROE 13.84%
ROIC 12.85%
ROA(3y)5.1%
ROA(5y)5.87%
ROE(3y)12.25%
ROE(5y)15.27%
ROIC(3y)15.03%
ROIC(5y)14.74%
IRO.CA Yearly ROA, ROE, ROICIRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

The Profit Margin of IRO (1.79%) is better than 70.59% of its industry peers.
In the last couple of years the Profit Margin of IRO has declined.
Looking at the Operating Margin, with a value of 2.91%, IRO is doing worse than 70.59% of the companies in the same industry.
In the last couple of years the Operating Margin of IRO has declined.
Looking at the Gross Margin, with a value of 12.78%, IRO is doing worse than 82.35% of the companies in the same industry.
In the last couple of years the Gross Margin of IRO has declined.
Industry RankSector Rank
OM 2.91%
PM (TTM) 1.79%
GM 12.78%
OM growth 3Y-3.42%
OM growth 5Y-9.22%
PM growth 3Y-4.47%
PM growth 5Y-13.53%
GM growth 3Y-0.96%
GM growth 5Y-7.1%
IRO.CA Yearly Profit, Operating, Gross MarginsIRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IRO is still creating some value.
IRO has less shares outstanding than it did 1 year ago.
IRO has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IRO has a worse debt to assets ratio.
IRO.CA Yearly Shares OutstandingIRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IRO.CA Yearly Total Debt VS Total AssetsIRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 4.80 indicates that IRO is not in any danger for bankruptcy at the moment.
The Altman-Z score of IRO (4.80) is better than 88.24% of its industry peers.
IRO has a debt to FCF ratio of 2.51. This is a good value and a sign of high solvency as IRO would need 2.51 years to pay back of all of its debts.
The Debt to FCF ratio of IRO (2.51) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that IRO is not too dependend on debt financing.
The Debt to Equity ratio of IRO (0.42) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 2.51
Altman-Z 4.8
ROIC/WACC1.5
WACC8.55%
IRO.CA Yearly LT Debt VS Equity VS FCFIRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

IRO has a Current Ratio of 1.96. This is a normal value and indicates that IRO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IRO (1.96) is better than 94.12% of its industry peers.
A Quick Ratio of 1.75 indicates that IRO should not have too much problems paying its short term obligations.
IRO's Quick ratio of 1.75 is amongst the best of the industry. IRO outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.75
IRO.CA Yearly Current Assets VS Current LiabilitesIRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

IRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.64%, which is quite good.
The Earnings Per Share has been growing slightly by 1.74% on average over the past years.
Looking at the last year, IRO shows a small growth in Revenue. The Revenue has grown by 4.58% in the last year.
IRO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.29% yearly.
EPS 1Y (TTM)8.64%
EPS 3Y3.94%
EPS 5Y1.74%
EPS Q2Q%8.2%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y15.6%
Revenue growth 5Y17.29%
Sales Q2Q%3.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IRO.CA Yearly Revenue VS EstimatesIRO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.83, the valuation of IRO can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of IRO indicates a rather cheap valuation: IRO is cheaper than 88.24% of the companies listed in the same industry.
IRO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.45.
Industry RankSector Rank
PE 11.83
Fwd PE N/A
IRO.CA Price Earnings VS Forward Price EarningsIRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IRO is valued cheaper than 94.12% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IRO indicates a rather cheap valuation: IRO is cheaper than 94.12% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.43
EV/EBITDA 2.64
IRO.CA Per share dataIRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)6.8
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTER-ROCK MINERALS INC

TSX-V:IRO (6/30/2025, 7:00:00 PM)

0.71

+0.02 (+2.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners49.68%
Ins Owner ChangeN/A
Market Cap15.53M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.83
Fwd PE N/A
P/S 0.11
P/FCF 4.43
P/OCF 3.28
P/B 0.88
P/tB 1.06
EV/EBITDA 2.64
EPS(TTM)0.06
EY8.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY22.55%
OCF(TTM)0.22
OCFY30.45%
SpS6.22
BVpS0.8
TBVpS0.67
PEG (NY)N/A
PEG (5Y)6.8
Profitability
Industry RankSector Rank
ROA 5.95%
ROE 13.84%
ROCE 15.51%
ROIC 12.85%
ROICexc 20.41%
ROICexgc 24.88%
OM 2.91%
PM (TTM) 1.79%
GM 12.78%
FCFM 2.57%
ROA(3y)5.1%
ROA(5y)5.87%
ROE(3y)12.25%
ROE(5y)15.27%
ROIC(3y)15.03%
ROIC(5y)14.74%
ROICexc(3y)20.97%
ROICexc(5y)19.44%
ROICexgc(3y)27.38%
ROICexgc(5y)26.29%
ROCE(3y)18.14%
ROCE(5y)17.79%
ROICexcg growth 3Y0.56%
ROICexcg growth 5Y2.12%
ROICexc growth 3Y6.13%
ROICexc growth 5Y6.02%
OM growth 3Y-3.42%
OM growth 5Y-9.22%
PM growth 3Y-4.47%
PM growth 5Y-13.53%
GM growth 3Y-0.96%
GM growth 5Y-7.1%
F-Score6
Asset Turnover3.32
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 2.51
Debt/EBITDA 1.3
Cap/Depr 74.38%
Cap/Sales 0.9%
Interest Coverage 15.86
Cash Conversion 84.22%
Profit Quality 143.81%
Current Ratio 1.96
Quick Ratio 1.75
Altman-Z 4.8
F-Score6
WACC8.55%
ROIC/WACC1.5
Cap/Depr(3y)98.67%
Cap/Depr(5y)71.94%
Cap/Sales(3y)1.1%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y3.94%
EPS 5Y1.74%
EPS Q2Q%8.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.58%
Revenue growth 3Y15.6%
Revenue growth 5Y17.29%
Sales Q2Q%3.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.73%
EBIT growth 3Y11.65%
EBIT growth 5Y6.48%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8690%
FCF growth 3Y-10%
FCF growth 5Y0.86%
OCF growth 1Y438.7%
OCF growth 3Y1.84%
OCF growth 5Y2.88%